Hsa_circ_0002483 inhibited the progression and enhanced the Taxol sensitivity of non-small cell lung cancer by targeting miR-182-5p

被引:105
作者
Li, Xiaoping [1 ]
Yang, Bo [1 ]
Ren, Haixia [2 ]
Xiao, Ting [3 ]
Zhang, Liang [1 ]
Li, Lei [1 ]
Li, Mingjiang [1 ]
Wang, Xuhui [1 ]
Zhou, Honggang [4 ]
Zhang, Weidong [1 ]
机构
[1] Tianjin First Cent Hosp, Dept Thorac Surg, Tianjin 300192, Peoples R China
[2] Tianjin First Cent Hosp, Dept Pharm, Tianjin 300192, Peoples R China
[3] Nankai Univ, State Key Lab Med Chem Biol, Coll Pharm, Tianjin 300350, Peoples R China
[4] Nankai Univ, Tianjin Int Joint Acad Biomed, Coll Pharm, Tianjin Key Lab Mol Drug Res, Tianjin 300350, Peoples R China
关键词
PACLITAXEL; RESISTANCE; EFFICACY;
D O I
10.1038/s41419-019-2180-2
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
In this study, we identified a novel circRNA, circ_0002483, and further investigated its functions in the progression and Taxol resistance of NSCLC. We found that circ_0002483 was expressed at low levels in NSCLC tissues and cell lines. Functional assays indicated that circ_0002483 overexpression significantly inhibited NSCLC cell proliferation and invasion in vitro and in vivo and enhanced the sensitivity of NSCLC cells to Taxol. Mechanistically, circ_0002483 was identified to sponge multiple miRNAs including miR-182-5p (also named miR-182), miR-520q-3p, miR-582-3p, miR-587, and miR-655. In addition, circ_0002483 was also demonstrated to regulate the expression of GRB2, FOXO1, and FOXO3, three target genes of miR-182-5p, by sponging miR-182-5p. Circ_0002483 was demonstrated to inhibit NSCLC progression in vitro and in vivo and enhanced the sensitivity of NSCLC cells to Taxol by sponging miR-182-5p to release the inhibition on GRB2, FOXO1, and FOXO3 mRNAs.
引用
收藏
页数:12
相关论文
共 30 条
[1]  
Buyukcelik A, 2004, NEW ENGL J MED, V350, P2009
[2]   Re-interpretation of PAM50 gene expression as quantitative tumor dimensions shows utility for clinical trials: application to prognosis and response to paclitaxel in breast cancer [J].
Camp, Nicola J. ;
Madsen, Michael J. ;
Herranz, Jesus ;
Rodriguez-Lescure, Alvaro ;
Ruiz, Amparo ;
Martin, Miguel ;
Bernard, Philip S. .
BREAST CANCER RESEARCH AND TREATMENT, 2019, 175 (01) :129-139
[3]   Pregnane X receptors regulate CYP2C8 and P-glycoprotein to impact on the resistance of NSCLC cells to Taxol [J].
Chen, Yan ;
Huang, Wandan ;
Chen, Feiyu ;
Hu, Guoping ;
Li, Fenglei ;
Li, Jianhua ;
Xuan, Aiguo .
CANCER MEDICINE, 2016, 5 (12) :3564-3571
[4]   The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer [J].
Goldstraw, Peter ;
Chansky, Kari ;
Crowley, John ;
Rami-Porta, Ramon ;
Asamura, Hisao ;
Eberhardt, Wilfried E. E. ;
Nicholson, Andrew G. ;
Groome, Patti ;
Mitchell, Alan ;
Bolejack, Vanessa .
JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (01) :39-51
[5]  
Jemal A, 2010, CA-CANCER J CLIN, V60, P277, DOI [10.3322/caac.21254, 10.3322/caac.20073]
[6]   Investigation of prognostic factors affecting efficacy in carboplatin- and paclitaxel-based first-line chemotherapies for advanced non-small-cell lung cancer [J].
Komuro, Masato ;
Kaneko, Masayuki ;
Narukawa, Mamoru .
TUMORI JOURNAL, 2015, 101 (04) :424-432
[7]   Non-Coding RNAs in Endometrial Physiopathology [J].
La Ferlita, Alessandro ;
Battaglia, Rosalia ;
Andronico, Francesca ;
Caruso, Salvatore ;
Cianci, Antonio ;
Purrello, Michele ;
Di Pietro, Cinzia .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (07)
[8]   Daurinoline suppressed the migration and invasion of chemo-resistant human non-small cell lung cancer cells by reversing EMT and Notch-1 and sensitized the cells to Taxol [J].
Li, Dan-Dan ;
Qin, Xiao-Chun ;
Yang, Yue ;
Chu, Hai-Xiao ;
Li, Ruo-Lan ;
Ma, Ling-xiang ;
Ding, Huai-Wei ;
Zhao, Qing-Chun .
ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY, 2019, 66 :109-115
[9]   One size does not fit all [J].
Lovly, Christine M. ;
Carbone, David P. .
NATURE REVIEWS CLINICAL ONCOLOGY, 2011, 8 (02) :68-70
[10]   CHARACTERIZATION OF A TAXOL-RESISTANT HUMAN SMALL-CELL LUNG-CANCER CELL-LINE [J].
OHTA, S ;
NISHIO, K ;
KUBOTA, N ;
OHMORI, T ;
FUNAYAMA, Y ;
OHIRA, T ;
NAKAJIMA, H ;
ADACHI, M ;
SAIJO, N .
JAPANESE JOURNAL OF CANCER RESEARCH, 1994, 85 (03) :290-297